Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer.
Severson TM, Minnee E, Zhu Y, Schuurman K, Nguyen HM, Brown LG, Hakkola S, Menezes R, Gregoricchio S, Kim Y, Kneppers J, Linder S, Stelloo S, Lieftink C, van der Heijden MS, Nykter M, van der Noort V, Sanders J, Morris B, Jenster G, van Leenders GJ, Pomerantz M, Freedman ML, Beijersbergen RL, Urbanucci A, Wessels L, Nelson PS, Corey E, Prekovic S, Zwart W, Bergman AM.
Severson TM, et al.
Cell Rep Med. 2025 Jun 27:102215. doi: 10.1016/j.xcrm.2025.102215. Online ahead of print.
Cell Rep Med. 2025.
PMID: 40609538
Free article.